Fig. 10From: Integrated bioinformatics analysis for conducting a prognostic model and identifying immunotherapeutic targets in gastric cancerAnalysis of IPS in low- and high-risk groups. IPS calculated by expression of CTLA4 and PD1 A ctla4_neg_pd1_neg B ctla4_pos_pd1_neg C ctla4_neg_pd1_pos D ctla4_pos_pd1_posBack to article page